We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Quince Therapeutics, Inc. operates as a biopharmaceutical company. The Company focuses on advancing precision therapeutics designed to precisely deliver small molecules, peptides, and large molecules directly to the site of bone diseases to promote more rapid healing with fewer off-target safety con... Quince Therapeutics, Inc. operates as a biopharmaceutical company. The Company focuses on advancing precision therapeutics designed to precisely deliver small molecules, peptides, and large molecules directly to the site of bone diseases to promote more rapid healing with fewer off-target safety concerns. Quince Therapeutics serves customers in the United States. Show more
Quince Therapeutics, Inc. (Nasdaq: QNCX), a late-stage biotechnology company dedicated to unlocking the power of a patientβs own biology for the treatment of rare diseases, today announced that...
Findings from largest completed study in A-T demonstrated favorable safety profile Study showed positive effect of EryDex treatment in a subset of patients with A-T ages six to nine β the age...
Strong cash position expected to provide sufficient operating runway into 2026; Phase 3 topline results expected in the fourth quarter of 2025 Quince Therapeutics, Inc. (Nasdaq: QNCX), a...
Quince Therapeutics, Inc. (Nasdaq: QNCX), a late-stage biotechnology company developing an innovative drug delivery technology designed to leverage a patientβs own biology to deliver rare disease...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.066 | -8.68421052632 | 0.76 | 0.818 | 0.69 | 34191 | 0.72320065 | CS |
4 | -0.036 | -4.93150684932 | 0.73 | 0.8699 | 0.69 | 65772 | 0.78071795 | CS |
12 | -0.046 | -6.21621621622 | 0.74 | 0.8699 | 0.5116 | 164554 | 0.62447041 | CS |
26 | -0.256 | -26.9473684211 | 0.95 | 1.12 | 0.5116 | 132061 | 0.72174616 | CS |
52 | -0.296 | -29.898989899 | 0.99 | 1.4301 | 0.5116 | 104220 | 0.8642598 | CS |
156 | -75.716 | -99.0917419186 | 76.41 | 81.5599 | 0.5116 | 601313 | 6.59533632 | CS |
260 | -23.056 | -97.0778947368 | 23.75 | 121.98 | 0.5116 | 436589 | 14.64096934 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions